Welcome to LookChem.com Sign In|Join Free
  • or
Carbamic acid, [(methoxycarbonyl)oxy]-, 1,1-dimethylethyl ester (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

27920-29-2

Post Buying Request

27920-29-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27920-29-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 27920-29-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,9,2 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 27920-29:
(7*2)+(6*7)+(5*9)+(4*2)+(3*0)+(2*2)+(1*9)=122
122 % 10 = 2
So 27920-29-2 is a valid CAS Registry Number.

27920-29-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl [(2-methylpropan-2-yl)oxycarbonylamino] carbonate

1.2 Other means of identification

Product number -
Other names N-tert-Butyloxycarbonyl-O-methoxycarbonyl-hydroxylamin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27920-29-2 SDS

27920-29-2Relevant academic research and scientific papers

Bis-Acylated Hydroxylamine Derivatives

-

Page/Page column 48-49, (2011/06/24)

The invention provides certain bis-acylated hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the invention provides methods of using such compounds or pharmaceutical compositions for treating, preventing, or delaying the onset and/or develop of a disease or condition. In some embodiments, the disease or condition is selected from cardiovascular diseases, ischemia, reperfusion injury, cancerous disease, pulmonary hypertension and conditions responsive to nitroxyl therapy.

A Synthesis of N-Acyl-1,2-dihydropyridines

Wyle, Michael J.,Fowler, Frank W.

, p. 4025 - 4029 (2007/10/02)

A new approach to the synthesis of N-acyl-1,2-dihydropyridines based on the cyclization of N-acyl-1-azatrienes is introduced.These latter compounds were not isolated but were produced in the gas phase as transient intermediates by the flash vacuum pyrolysis of O-methoxycarbonyl N-penta-1,3-dien-5-yl hydroxamic acid derivatives 8.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 27920-29-2